Dolutegravir based two-drug regimen in clinical routine

被引：0
|
作者：
Hoeller, Hannes [1 ]
Jaeger, Hans [1 ]
Jonsson-Oldenbuettel, Celia [1 ]
Heldwein, Silke [1 ]
Schabaz, Farhad [1 ]
von Krosigk, Ariane [1 ]
Wiese, Carmen [1 ]
Wolf, Eva [2 ]
Noe, Sebastian [1 ]
机构：
[1] MVZ Munchen Goethepl, Munich, Germany
[2] MUC Res GmbH, Munich, Germany
来源：
INFECTION | 2021年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
016
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] Comparison of a two-drug regimen (dolutegravir/rilpivirine) to standard three-drug regimens in virologically suppressed, treatment experienced individuals in the real world
    Pierone, G.
    Schulman, K.
    Fusco, J.
    Vannappagari, V.
    Aboud, M.
    Ragone, L.
    Fusco, G.
    HIV MEDICINE, 2019, 20 : 71 - 72
  • [22] Pharmacokinetic and pharmacokinetic/pharmacodynamic characterization of the dolutegravir/rilpivirine two-drug regimen in SWORD-1/-2 phase 3 studies
    Mehta, Rashmi
    Lagishetty, Chakradhar V.
    Angelis, Konstantinos
    Aylott, Alicia
    Kahl, Lesley
    Blair, Libby
    Matthews, Jessica
    Wynne, Brian
    Crauwels, Herta
    Underwood, Mark
    Adkison, Kimberly K.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (07) : 2190 - 2200
  • [23] Two-drug regimens with dolutegravir for maintaining viral suppression: looking at the right companion
    Castagna, Antonella
    Ladisa, Nicoletta
    Roldan, Maria Eugenia Quiros
    Ferraresi, Alice
    Mena, Maurizio
    Rusconi, Stefano
    Riva, Agostino
    Atzori, Chiara
    Frigerio, Marta
    Falvella, Felicia Stefania
    Cattaneo, Dario
    Spagnuolo, Vincenzo
    Poli, Andrea
    Galli, Laura
    Castagna, Antonella
    Cattelan, Anna Maria
    Cavinato, Silvia
    Mazzola, Gianni
    Cascio, Antonio
    Gulminetti, Roberto
    Pagnucco, Layla
    De Socio, Giuseppe Vittorio
    Di Giambenedetto, Simona
    Ciccullo, Arturo
    Bonora, Stefano
    Ferrara, Micol
    Carosella, Sinibaldo
    AIDS, 2019, 33 (14) : 2264 - 2266
  • [24] Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection
    Mehta, Rashmi
    Wolstenholme, Allen
    Di Lullo, Kristin
    Fu, Caifeng
    Joshi, Shashidhar
    Crauwels, Herta
    Givens, Naomi
    Vanveggel, Simon
    Wynne, Brian
    Adkison, Kimberly
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [25] Effectiveness and tolerability of the two-drug regimen dolutegravir plus lamivudine in people with HIV-1: a systematic literature review of real-world evidence from clinical practice
    Letang, Emilio
    Priest, Julie
    Di Giambenedetto, Simona
    Monforte, Antonella d'Arminio
    Casado, Jose
    Cabello-Ubeda, Alfonso
    Hocqueloux, Laurent
    Allavena, Clotilde
    Barber, Tristan J.
    Jha, Diwakar
    Kamath, Rahul Dinesh
    Sithamparanathan, Myooran
    van Wyk, Jean
    Evitt, Lee
    HIV MEDICINE, 2022, 23 : 37 - 38
  • [26] Durable efficacy of switching from a three-/four-drug tenofovir alafenamide (TAF)-based regimen to the two-drug regimen dolutegravir/lamivudine (DTG/3TC) in the TANGO study through week 196
    De Wit, S.
    Bonnet, F.
    Osiyemi, O.
    Bisshop, F.
    Olalla, J.
    Routy, J.
    Wyen, C.
    Moodley, R.
    Pappa, K.
    Wang, R.
    Oyee, J.
    Saggu, P.
    Letang, E.
    Wynne, B.
    Jones, B.
    Smith, K.
    Ait-Khaled, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 12 - 13
  • [27] Is Antiretroviral Two-Drug Regimen the New Standard for HIV Treatment in Naive Patients?
    Dupont, Emilie
    Yombi, Jean Cyr
    AIDS REVIEWS, 2019, 21 (03) : 143 - 156
  • [28] Two-Drug Regimen Containing Darunavir: Metabolic Evaluation of an Old Dual Therapy
    Farinacci, Damiano
    Iannone, Valentina
    D'Angelillo, Anna
    Borghetti, Alberto
    Passerotto, Rosa Anna
    Lamanna, Francesco
    Di Giambenedetto, Simona
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2023, 39 (12) : 633 - 635
  • [29] Uptake Success and Cost Savings from Switching to a Two-Drug Antiretroviral Regimen
    Krentz, Hartmut B.
    Campbell, Shayna
    Lahl, Morgan
    Gill, M. John
    AIDS PATIENT CARE AND STDS, 2021, 36 (01) : 1 - 7
  • [30] THE RELATIVE SAFETY OF A PROMISING TRIPLE DRUG MASS DRUG ADMINISTRATION REGIMEN VERSUS A TWO-DRUG REGIMEN FOR LYMPHATIC FILARIASIS ELIMINATION IN INDIA
    Purushothaman, Jambulingam
    Kuttiatt, Vijesh
    Swaminathan, Subramanian
    Kaliannagounder, Krishnamoorthy
    Adinarayanan, Srividya
    Weil, Gary
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 614 - 614
12345